Diagnostic and Interventional Cardiology

In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents in all diseased arteries was found to be as safe and effective at one year of follow-up as staged treatment, according to findings from the first large, randomized trial to address this question that is being presented at the American College of Cardiology’s Annual Scientific Session Together With the World Congress of Cardiology.

Immediate Complete Revascularization as Safe and Effective as Staged Procedure in Treating Multi-Vessel Disease

March 5, 2023 — In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents ...

March 05, 2023

COAPT trial demonstrates long-term benefits of transcatheter procedure in high-risk patients with heart failure

News | Structural Heart

Minimally Invasive Mitral Valve Repair Reduces Hospitalizations and Deaths

March 5, 2023 — In patients with heart failure and a poorly functioning heart valve, a minimally invasive procedure ...

March 05, 2023

Newer technique is equally safe and effective when performed by experienced surgeons, according to investigators

News | Cardiovascular Clinical Studies

March 5, 2023 — In the largest randomized trial conducted to compare minimally invasive and conventional cardiac ...

March 05, 2023

Sponsored Content

Feature | Nuclear Imaging

Cardiac PET/CT — A New Standard for Cardiac Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

November 12, 2025

The Opening Showcase of the American College of Cardiology's Annual Scientific Session Together with the World Congress of Cardiology, ACC.23/WCC, featured comments from Ed Fry, MD, ACC President, shown here, the event Chair and World Heart Federation President. the 3-day global gathering of cardiologists is taking place March 4-6 in New Orleans, LA.

Feature | ACC | Christine Book

Important Clinical Trial Outcomes, the Evolution of Cardiac ICU and Young Authors Take Center Stage for Global Gathering of Cardiologists in New Orleans ACC.23/WCC

March 4, 2023 — Of the immense volume of valuable information offered and exchanged during the first day of the American ...

March 04, 2023

News | ACC

STOP-CA Clinical Trial Finds Statins Lower Rate of Heart Decline in Lymphoma Patients, Late-Breaking ACC23 Clinical Trial Reports

March 4, 2023 — The impact of statin use to prevent heart damage during a cancer patient’s chemotherapy was in focus ...

March 04, 2023

News | ACC

TRILUMINATE Pivotal Trial Findings Reported at ACC.23/WCC Reveal Impact of Improved Tricuspid Valve Functioning

March 4, 2023 — Findings from the TRILUMINATE Pivotal Trial found no significant difference in survival or ...

March 04, 2023

Sponsored Content

Feature

Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

June 17, 2025

Statistically significant reduction in the risk for the primary outcome on Day 27

News | Heart Failure

New Analyses of Sotagliflozin Showing Time to Clinical Benefit Presented at ACC23

March 4, 2023 - Lexicon Pharmaceuticals, Inc. announced new analyses of results from the SOLOIST-WHF Phase 3 outcomes ...

March 04, 2023

Viz.ai’s AI-powered clinical research platform will be used to find, screen and enroll patients in a landmark study of catheter-directed therapy for pulmonary embolism

News | Artificial Intelligence

Viz.ai to Expedite Patient Enrollment in NIH-funded PE-TRACT Clinical Trial

March 4, 2023 — Viz.ai, a leader in AI-powered disease detection and care coordination, announced it will use its VizTM ...

March 04, 2023

News | ACC

CLEAR Trial Reported at ACC23 Finds Bempedoic Acid Lowers LDL Cholesterol, Reduces Risk of Serious Cardiovascular Outcomes in Statin-Intolerant Patients

March 4, 2023 — The cholesterol-lowering drug bempedoic acid was found to reduce the combined rate of major adverse ...

March 04, 2023

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Late-breaking data presented at American College of Cardiology Scientific Sessions (ACC.23) and simultaneously published in The New England Journal of Medicine demonstrate TriClip was superior to medical therapy with significant improvements in quality of life and tricuspid regurgitation (TR)

News | Structural Heart

New Data Show Superiority of Abbott's TriClip Device Compared to Medical Therapy for Tricuspid Regurgitation

March 4, 2023 — Abbott announced late-breaking data for the TriClip transcatheter edge-to-edge repair (TEER) system, a ...

March 04, 2023

News | ACC

GE HealthCare to Present Continuum of Care Innovations in Cardiology at ACC.23/WCC

March 4, 2023 — GE HealthCare will present its latest technologies and innovations for use during the critical planning ...

March 04, 2023

iRhythm continues to expand its strong body of clinical and scientific evidence with new research presented by leading clinical investigators at the conference

News | ACC

Four New Studies Featuring Zio by iRhythm to be Presented at ACC.23/WCC

March 3, 2023 — iRhythm Technologies, Inc. , a leading digital health company focused on creating trusted solutions that ...

March 03, 2023

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

Machine learning can be used to help clinicians with early diagnosis

News | Heart Failure

Rutgers Researchers Use Artificial Intelligence to Predict Cardiovascular Disease

March 3, 2023 — Researchers may be able to predict cardiovascular disease – such as atrial fibrillation and heart ...

March 03, 2023

News | FFR Technologies

CathWorks to Present Outcomes from International Real-World FFRangio Registry to be Presented at ACC 2023

March 3, 2023 —CathWorks announced key events for the company during the annual American College of Cardiology (ACC) ...

March 03, 2023

Experiencing lasting symptoms months after catching COVID-19, known as long COVID, was found to more than double a person’s likelihood of developing cardiovascular issues, according to a study being presented at the American College of Cardiology’s Annual Scientific Session Together with the World Congress of Cardiology, ACC.23/WCC, taking place March 4-6, 2023, in New Orleans, LA.

News | Coronavirus (COVID-19)

ACC23 Study Finds Long COVID More Than Doubles Risk of Developing New Cardiac Symptoms

March 3, 2023 — Experiencing lasting symptoms months after catching COVID-19, known as long COVID, was found to more ...

March 03, 2023